2-ethylhexane-1-thiol | CAS:7341-17-5

We serve 2-ethylhexane-1-thiol CAS:7341-17-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-ethylhexane-1-thiol

Chemical Name:2-ethylhexane-1-thiol
CAS.NO:7341-17-5
Synonyms:2-ethylhexane-1-thiol
2-ethyl-hexane-1-thiol
2-Aethyl-hexylmercaptan
2-Ethylhexylmercaptan
2-Ethylhexanethiol
Molecular Formula:C8H18S
Molecular Weight:146.29400
 
Physical and Chemical Properties:
Density:0.843
Boiling point:188.4ºC
Flash point:55.7ºC
Index of Refraction:1.457
 
Specification:
Appearance:Colourless to yellow liquid
Assay:≥97.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-ethylhexane-1-thiol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Ethylhexanethiol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-ethyl-hexane-1-thiol Use and application,2-ethyl-hexane-1-thiol technical grade,usp/ep/jp grade.


Related News: In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.4-(3-Chloropropyl)morpholine manufacturer A number of UK citizens who failed to leave the coronavirus-struck Chinese city of Wuhan last week are now on a second flight to Europe, UK Foreign Secretary Dominic Raab said Sunday.2-hydroxy-6-oxo-4-(trifluoromethyl)-1H-pyridine-3-carbonitrile supplier A number of UK citizens who failed to leave the coronavirus-struck Chinese city of Wuhan last week are now on a second flight to Europe, UK Foreign Secretary Dominic Raab said Sunday.Ethyl 2-methylacetoacetate vendor The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.